Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population.

Abstract

Compliance with statin therapy in the managed care setting remains poor. Of particular concern is the lower level of compliance among women and younger high-risk patients, along with patients who have fewer outpatient visits associated with hyperlipidemia and lower incidences of cholesterol testing.